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TAHAP KETERUKAN PREEKLAMPSIA DAN FAKTOR-FAKTOR YANG 
BERKAITAN DI HOSPITAL UNIVERSITI SAINS MALAYSIA 
 
ABSTRAK 
 
Latar belakang kajian: Preeklampsia (PE) adalah salah satu punca utama kepada 
kematian dan mobiditi ibu di seluruh dunia. PE berlaku selepas 20 minggu kehamilan 
dengan kehadiran tekanan darah tinggi dan protin dalam air kencing. Kajian ini dijalankan 
bertujuan untuk menentukan peratus dan faktor-faktor penyebab PE berdasarkan tahap 
keterukan dalam kalangan pesakit di Hospital USM. Metodologi: Kajian rentas ini 
dijalankan ke atas 200 pesakit yang didiagnosa sebagai PE antara tahun 2011 hingga 2016 
yang mengikuti rawatan susulan semasa kehamilan hingga proses kelahiran. Pesakit yang 
dirujuk dari hospital lain di Kelantan dan negeri lain yang terdekat juga dikira sebagai 
sampel kajian. Selain itu, pesakit yang menghidapi tekanan darah tinggi kronik sebelum 
PE, sindrom hemolisis, enzim hati yang tinggi, dan kiraan platelet rendah (HELLP) dan 
eklampsia juga termasuk dalam kriteria kajian. Pengkelasan tahap keterukan dibahagikan 
kepada ringan, sederhana dan teruk seperti yang ditetapkan oleh garis panduan Institut 
Kecemerlangan Kesihatan dan Penjagaan Kebangsaan (NICE). Regresi logistik ordinal 
telah digunakan untuk menganalisis. Dapatan kajian: Peratus pesakit yg menghidapi PE 
tahap ringan adalah sebanyak 34.7%, tahap sederhana sebanyak 30.2% dan tahap teruk 
sebanyak 35.1%. Asid urik yang tinggi didapati meningkatkan risiko untuk mendapat PE 
pada tahap yang lebih teruk (nisbah odds terlaras: 1.05, 95% selang keyakinan (SK): 1.02, 
1.07). Tekanan darah tinggi kronik (nisbah odds terlaras: 2.36, 95% SK: 1.28, 4.33) dan 
  xv 
 
diabetes semasa hamil (nisbah odds terlaras: 0.53, 95% SK: 0.30, 0.96) juga didapati 
mempunyai kaitan dengan tahap keterukan PE. Kesimpulan: Mereka yang mengalami 
tahap PE yang ringan dan teruk didapati lebih tinggi berbanding tahap sederhana dalam 
populasi kajian ini. Pesakit dengan asid urik yang tinggi dan tekanan darah tinggi kronik 
lebih berisiko untuk mendapat PE yang teruk, manakala pesakit yang mengalami diabetes 
semasa hamil lebih cenderung mendapat PE yang ringan. Asid urik, tekanan darah tinggi 
kronik dan diabetes semasa hamil adalah berkaitan dengan bererti mengikut tahap 
keterukan PE dalam kalangan pesakit di Hospital USM. Pemeriksaan berkala terhadap 
tekanan darah dan protein dalam air kencing perlu diamalkan pada setiap pemeriksaan 
antenatal seperti yang dicadangkan oleh Pertubuhan Kesihatan Sedunia. 
 
Kata kunci: preeklampsia, tahap keterukan, peratus, asid urik, tekanan darah tinggi, 
diabetes semasa hamil
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THE SEVERITY OF PREECLAMPSIA AND ITS ASSOCIATED FACTORS IN 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
 
ABSTRACT 
 
Background: Preeclampsia (PE) is one of the leading cause of maternal mortality and 
morbidity worldwide. It occurs after 20 weeks of gestation with the presence of 
hypertension and proteinuria. The aim of this study was to determine the proportion and 
the associated factors of PE according to its severity among patients in Hospital USM. 
Methods: A cross-sectional study involving 200 patients diagnosed with PE between years 
of 2011 to 2016 who were followed up and delivered in Hospital USM were included in 
this study. Patients from other referral hospitals in Kelantan and nearer states were also 
included to be the study samples. We also include those of chronic hypertension with 
superimposed PE, hemolysis, elevated liver enzymes, and low platelet count (HELLP) 
syndrome, and eclampsia. The severity classification of mild, moderate and severe PE was 
determined based on the National Institute of Health and Care Excellence (NICE) 
guideline. Ordinal logistic regression was used for analyzing. Results: The percentage of 
PE among patients in Hospital USM were found to be 34.7% in mild, 30.2% in moderate 
and 35.1% in severe cases. Higher uric acid resulted in greater odds of getting severe versus 
mild PE (Adjusted odds ratio (OR): 1.05, 95% CI: 1.02, 1.07) after adjusted for other 
variables. Patients having chronic hypertension (Adjusted OR: 2.36, 95% CI: 1.28, 4.33) 
and gestational diabetes mellitus (GDM) (Adjusted OR: 0.53, 95% CI: 0.30, 0.96) were 
also found to be associated with the severity of PE. Conclusion: Those who developed 
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mild and severe PE was higher compared to moderate PE in this population. Patients with 
high uric acid and chronic hypertension have higher chances to get severe PE, while those 
with GDM was more likely to have mild PE. Uric acid, chronic hypertension, and GDM 
were significantly found to be associated with the severity of PE among patients in Hospital 
USM. A routine screening for PE based on BP and urine protein measurement should be 
practiced and done at every antenatal visit as recommended by World Health Organization 
(WHO). 
 
Keywords: preeclampsia, severity, proportion, uric acid, chronic hypertension, GDM 
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 CHAPTER 1 
       INTRODUCTION 
 
1.1 Background of Study 
 
Hypertensive disorders of pregnancy remain one of the leading causes of maternal and 
perinatal morbidity and mortality for about 3-8% worldwide (Carty et al., 2010). 
Preeclampsia (PE) is a common disorder characterized by hypertension in pregnancy and 
complicates about 2-8% of all pregnancies in the developed world (Steegers et al., 2010). 
Maternal systolic blood pressure (SBP) ≥ 160 mm Hg and/or diastolic blood pressure 
(DBP) ≥ 110 mm Hg was defined as severe PE and if remains untreated, it could lead 
toward more serious condition known as eclampsia (Al-Jameil et al., 2013). Severe PE was 
associated with an increased risk of adverse outcomes in pregnancy (Wilkinson, 2011). 
Women who did not reach BP of 140 or 90 mmHg, but had been detected a rise of > 30/15 
mmHg from booking or preconception BP, had in the past been considered useful in 
diagnosing PE instead of relying on an absolute value (CPG, 2013; Lowe et al., 2015). 
 
Based on the Malaysia Clinical Research Center (CRC) review of hypertensive disorders 
in pregnancy from the year 2011 until 2012, the data showed that incidence of PE was 
19.6%, chronic hypertension was 18.6%, chronic hypertension of superimposed PE was 
6.7% and gestational hypertension of 53.3%, which was the commonest type of 
hypertensive disorders in pregnancy among Malaysian women (Yadav, 2012). 
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A recent study done in three hospitals in Riyadh, Saudi Arabia found that PE occurred in 
1.2% among Saudi women (Wahabi et al., 2016), and 2.23% among women who referred 
to Dilla University Referral Hospital, Ethiopia (Vata et al., 2015). 
 
Consequently, PE can affect both mother and the baby. Anderson et al. (2012) noted that 
PE women was 25.8% higher chance of delivering preterm infants and 28.5% of getting 
small gestational age (SGA) infants compared to those without PE. The rate of Neonatal 
Intensive Care Unit (NICU) admission was significantly higher for those mother with PE 
than in those from mother with gestational hypertension (38.8% versus 25.7%). Fetal and 
neonatal death was also noted to be higher in PE group compared to the gestational 
hypertension group (Shiozaki et al., 2013).  
 
Hence, the major complications for women with PE include central nervous system (CNS) 
injuries such as seizures (eclampsia), hemorrhagic and ischemic strokes, hepatic damage 
ranging from transaminase elevation known as HELLP syndrome (hemolysis, elevated 
liver enzymes, and low platelets), hepatic failure, and renal dysfunction (Mustafa et al., 
2012). 
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1.2 Problem Statement 
 
The assessment of the severity of PE in pregnancy was based on the clinical examination 
of patient with the presence of proteinuria. Different investigations would determine 
different level of the severity of PE among patients. However, the severity classification of 
mild, moderate and severe PE had not been specified in Hospital USM medical birth 
register. Whereas the information on the severity of PE and their associated factors were 
lacked among pregnant Malaysian women. 
 
1.3  Justification of the Study 
 
There would be some benefits of doing this study, not only for the researchers but mainly 
very useful for clinicians as the information obtained can help them in identifying the 
associated factors of PE according to the severity of either mild, moderate or severe. From 
this information, they can educate patients and increase patients’ knowledge and awareness 
about PE and its consequences. This study would also provide them with the proportion of 
developing PE among patients in Hospital USM. The severity of PE was classified into 
mild, moderate and severe referring the National Institute of Health and Care Excellence 
(NICE) as a main guideline. In addition, since no similar study had been done on the factors 
associated with the severity of PE, the finding could help in providing extra information 
on the severity of PE in the local population. 
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 CHAPTER 2 
      OBJECTIVES 
 
2.1 Research Question 
 
1. What was the proportion of the severity of preeclampsia patients in Hospital USM? 
2. What were the associated factors of the severity of preeclampsia patients in 
Hospital USM? 
 
2.2 General Objective 
 
To determine the proportion and the associated factors of the severity of preeclampsia 
patients in Hospital USM. 
 
2.3 Specific Objectives 
 
Specifically, the objectives of the study were: 
1. To determine the proportion of the severity of preeclampsia patients in Hospital 
USM. 
2. To identify the associated factors of the severity of preeclampsia patients in 
Hospital USM. 
 5 
 
2.4 Hypothesis Statement 
 
There were significant associations between socio-demographics, clinical characteristics 
and laboratory parameters with the severity of PE among patients in Hospital USM. 
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 CHAPTER 3 
    LITERATURE REVIEW 
 
3.1 Hypertensive Disorders in Pregnancy 
 
Hypertensive disorders in pregnancy include chronic hypertension, gestational 
hypertension, preeclampsia (PE), and chronic hypertension with superimposed PE. They 
can affect both mother and the baby and thus result in substantial maternal morbidity and 
increase the chance of having cardiovascular disease later in future. Chronic hypertension 
occurs before 20 weeks of gestation including women with hypertension before pregnancy 
(pre-existing hypertension). Gestational hypertension occurs after 20 weeks of gestation 
without proteinuria assessment or any systematic findings. While PE presents after 20 
weeks of gestation with significant proteinuria or any symptoms of end-organ damage. 
Chronic hypertension with superimposed PE occurs when women with pre-existing 
hypertension also develops PE during the course of their pregnancy (NICE, 2013).  
 
In addition, Surapaneni et al. (2013) classified hypertension in pregnancy into chronic 
hypertension, gestational hypertension, preeclampsia (PE), eclampsia and HELLP 
syndrome. Hypertension was defined as a systolic blood pressure (SBP) of ≥ 140 mmHg 
and/or a diastolic blood pressure (DBP) of ≥ 90 mmHg, taken on at least two measures 
over several hours (Brown et al., 2001). Eclampsia occurs when women with PE develop 
seizures and HELLP syndrome represents the occurrence of hemolysis, elevated liver 
enzymes and low platelets among women with severe PE (Lowe et al., 2015). 
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3.2 Diagnosis of Preeclampsia and Its Severity 
 
A guideline from the Society of Obstetric Medicine of Australia and New Zealand 
(SOMANZ) defined PE as a raised in blood pressure during pregnancy with the 
involvement of other clinical manifestations (Lowe et al., 2015). They indicated that the 
presence of proteinuria was not mandatory for clinical diagnosis of PE. A diagnosis of PE 
was determined when increased in blood pressure occurs after 20 weeks gestation and was 
accompanied by any of the maternal organ dysfunction involving either renal insufficiency 
(a spot urine protein/creatinine ratio ≥ 30mg/mmol or serum creatinine > 90 μmol/L), 
hematological complications (thrombocytopenia or haemolysis), liver involvement (raised 
serum transaminases or severe epigastric and/or right upper quadrant pain), neurological 
complications (convulsions, persistent headache or visual disturbances), and uteroplacental 
dysfunction of fetal growth restriction.   
 
These symptoms of PE diagnosis were similar with the International Society for the Study 
of Hypertension in Pregnancy (ISSHP).  However, for severe PE, the recent ISSHP 
statement suggested that determining severity include the difficulty in controlling blood 
pressure and worsening clinical condition such as HELLP syndrome, impending 
eclampsia, thrombocytopenia or fetal growth restriction with less concern regarding 
increased of proteinuria (Tranquilli et al., 2014). The criteria for diagnosing severe PE were 
in line with several other studies (RCOG, 2006; American College of Obstetricians and 
Gynecologists (ACOG), 2013; CPG, 2013). 
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The assessment of the severity of PE during pregnancy was based on the clinical 
examination of the patients with the presence of proteinuria (Prakash et al., 2012). The 
American College of Obstetricians and Gynaecologists (ACOG) defined proteinuria as the 
excretion of 300 mg or more protein in a 24-hour urine collection or a protein/creatinine 
ratio of at least 0.3 mg/dL. If this approach is not readily available, diagnosis of proteinuria 
can be determined based on dipstick test of 1+ as a cut-off point (American College of 
Obstetricians and Gynecologists (ACOG), 2013). Recently, some guidelines (American 
College of Obstetricians and Gynecologists (ACOG), 2013; CPG, 2013; Tranquilli et al., 
2014; Lowe et al., 2015) no longer requires proteinuria for the diagnosis of PE, leaving 
only the British National Institute for Health and Care Excellence (NICE) guideline with 
this requirement (NICE, 2013). The measurement of proteinuria in pregnancy-induced 
hypertension has been reviewed by Lindheimer and Kanter (2010). The presence of 2+ or 
3+ proteinuria or repeated 1+ dipstick testing increased both sensitivity and specificity, 
thus was considered to represent significant proteinuria until proven otherwise by 
confirmatory tests. 
 
Some of the pregnancy guidelines classified PE as mild and severe or mild-moderate and 
severe (American College of Obstetricians and Gynecologists (ACOG), 2013; CPG, 2013; 
Magee et al., 2014; Lowe et al., 2015). A guideline which classified PE into mild, moderate 
and severe was NICE with inclusion of proteinuria assessment (NICE, 2010). They defined 
PE as a new onset of hypertension taken at least four hours apart on two measurements 
with the presence of significant proteinuria. The diagnosis of the severity of PE in this 
study was based on NICE guideline. Hence, PE was classified into three groups of mild, 
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moderate, and severe. Mild PE was diagnosed if SBP was between 140 to 149 mmHg 
and/or DBP was between 90 to 99 mmHg. While moderate was when SBP between 150 to 
159 mmHg and/or DBP was between 100 to 109 mmHg. Those with BP above 160/110 
mmHg were considered as having severe PE (NICE, 2013). 
 
3.3 Prevalence of the Severity of Preeclampsia among Pregnant Women 
 
PE affected about 6.4% among pregnant Iranian women (Allahyari et al., 2010) and 3.3% 
in New Zealand multiethnic pregnant women (Anderson et al., 2012). From a study done 
by Xiao et al. (2014) in China involving three hospitals, 2.35% of pregnant women 
developed PE, with 74.1% developed mild PE and the rest 25.9% were diagnosing of 
severe PE. Hence the prevalence of mild PE was 1.42% and that of severe PE was 0.49%. 
As compared with Caucasians, the prevalence of PE in this Chinese population was low 
due to better lifestyle practice such as diet, caloric intake, physical activity, geographical 
location, and genetic factors in China. For example in terms of dietary intake, they 
consumed a lot of tofu, one of the popular food in China with calcium-rich made from soy 
beans. Calcium supply in tofu has been shown to reduce the incidence of PE by up to 50% 
as reported by Hofmeyr et al. (2006). 
 
A previous study by Sohlberg et al. (2012) demonstrated that PE occurred in 4.8% among 
primiparous women who delivered a singleton baby in Sweden. The percentage for mild 
to moderate PE was 3.2% and 1.6% for severe PE in the population. They demonstrated 
that women of short stature and increase of body mass index (BMI) had higher risks of 
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both mild and severe PE. Those with BMI of more than 35 kg/m2 were four times higher 
chance to develop mild PE and three times of getting severe PE. Since it was reported that 
most of the women in the study were obese, then the proportion of getting mild was higher 
than severe PE.  
 
In addition, Direkvand-Moghadam et al. (2012) found out the prevalence of PE was 9.5% 
out of 610 pregnant women included in the study done at Mustafa Hospital of Ilam in the 
west of Iran. The prevalence of developing mild and severe PE was 1.3% and 8.2% 
respectively.  Higher prevalence of severe PE in this population was found to be associated 
with history of PE, hypertension, and infertility as well as low level of education among 
women. 
 
3.4 Proportion of the Severity of Preeclampsia among PE women 
 
Based on a study done by Alsnes et al. (2014) in Stavanger University Hospital, Norway, 
they discovered that the proportion of mild PE were 0.33, moderate PE was 0.42 and severe 
PE was 0.25. They noted that there was a decreased level of insulin resistance in severe 
group compared to the others, hence proven their hypothesis that women with mild and 
moderate PE were more likely deviated in metabolism and those of severe PE were mostly 
due to placental issue (Vatten and Skjaerven, 2004).  
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Meanwhile, in a study done by Vata et al. (2015) at Dilla University Referral Hospital, 
Ethiopia, the proportion of PE was noted to be 0.66 in mild group, 0.17 in severe group 
and the rest 0.17 in eclampsia group. It was noted that PE occurred in 10% of pregnancies 
in low-income countries including Africa, which considered higher compared to global 
average of approximately only 2% (Nakimuli et al., 2014).  
 
3.5 Factors Associated to the Severity of Preeclampsia 
3.5.1 Socio-Demographic Characteristics 
3.5.1.1 Maternal Age 
 
Various studies have shown a significant relationship between maternal age and the 
incidence of PE. Advanced of maternal age have been associated with a higher risk of 
developing PE. Trogstad et al. (2011) reported that the risk of developing more severe PE 
was almost twice for women aged 40 years and older compared to those of younger age. 
In addition, Tessema et al. (2015) pointed out that women aged 35 and above were 4.5 
times higher odds of experiencing PE than those aged 25 to 29 years (Adjusted OR: 4.5, 
95% CI: 1.56, 12.8), while those of 30 to 34 years were 3.3 times higher odds of developing 
PE than women with 25 to 29 years old (Adjusted OR: 3.26, 95% CI: 1.35, 7.8). 
 
A study done in Finland by Lamminpää et al. (2012) classified PE women aged 35 years 
and above as older age and compared to those under 35 as younger. They reported that 
women of advanced maternal age exhibited 9.4% more often of having more severe PE 
than younger women (6.4%). This was due to the fact that women with older age were at 
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higher risk of getting chronic diseases such as hypertension and DM and thus affect their 
pregnancies with deliveries of preterm or small gestational age infants.  
 
Vata et al. (2015) observed that 88.37% of PE women in their study group were in age of 
below 30 years old and the rest 11.63% were above 30. Conversely, they found a significant 
trend of association between women with younger age with increasing PE severity. They 
had concluded that younger women were more likely to develop severe PE compared to 
the elder one. It was mainly because of younger women had low level of awareness and 
knowledge on occurrence of PE during pregnancy. 
 
3.5.1.2 Pre-Pregnancy Body Mass Index (BMI) 
 
BMI was calculated as the ratio of maternal weight and height (kg/m2) at the first booking 
visit. According to the World Health Organization (WHO), overweight and obesity in 
adults were defined as an abnormal or excessive fat accumulation that may impair health 
status where an individual BMI respectively were 25 to 29.9 and above 30 kg/m2. However, 
WHO stated that the BMI classification for Asian/Indian women was different as the BMIs 
for normal, overweight and obese were 18.5 to 22.9, 23 to 27.4 and above 27.5 kg/m2, 
respectively (WHO Expert Consultation, 2004). The prevalence of obese women (BMI ≥ 
30 kg/m2) aged 18 and above in 2014 were 27.9% in Australia, 15.9% in Malaysia, 11.4% 
in Thailand, 8.2% in China, 8.1% in Indonesia, and about 5.1% in India (WHO Global 
Health Observatory data, 2016). 
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Several studies have highlighted the relationship between maternal obesity and PE. Based 
on the study done by Xiao et al. (2014), they found out that BMI was associated with the 
prevalence of PE among Chinese where 18.3% were overweight and 2.9% were obese. 
However, there was no significant association between mild and moderate PE with obesity. 
Being overweight and obese among women in China were less frequent as compared to 
European or American women (WHO Expert Consultation, 2004). Better consumption of 
dietary intake contributed to low prevalence of obesity among Chinese. 
 
While in Pittsburgh, Pennsylvania population, it was estimated that the prevalence of PE 
caused by obesity was 30% (Jeyabalan, 2013). Obesity increased risk of getting both mild 
and severe PE in the population as well as development of cardiovascular disease later in 
future (Roberts et al., 2011). In a retrospective cohort study of recorded maternity data 
from 2006 to 2009 in Auckland, New Zealand, Anderson et al. (2012) examined BMI of 
more than 27.5 kg/m2 was associated with a 2.6 fold increase in the risk of PE. Besides, 
Paré et al. (2014b) proved that those with BMI more than 25 kg/m2 were 64.4% greater 
risk of having severe PE. 
 
In addition, Sohlberg et al. (2012) proved that obesity with BMI ≥ 35 kg/m2 was associated 
with a 4 fold increase risk of mild to moderate PE and 3 fold increase risk of severe PE. 
This association showed that increasing BMI lead to a milder form of PE than severe. They 
also came up with a finding that women with a short stature had a greater chance of getting 
PE in pregnancy compared to those with tall stature (Adjusted OR: 1.3, 95% CI: 1.2, 1.5). 
There were stronger associations of short stature for severe than for mild to moderate PE 
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since they also claimed that women of short stature were at increased risk of cardiovascular 
disease. 
 
3.5.1.3 Parity 
 
Bai et al. (2002) defined parity as the number of how many times a woman had given birth 
to an infant from 20 weeks of gestation or weighed more than 0.4 kg. Nulliparity was a 
strong risk factor of PE (Adjusted OR: 2.4, 95% CI: 2.01, 2.86) as reported by Anderson 
et al. (2012). They noticed that there was no significant association between multiparous 
woman and risk of developing PE in the population. Other authors also demonstrated that 
nulliparous women were more likely to have severe PE than multiparous women (Kumar 
et al., 2014; Paré et al., 2014a). 
 
Furthermore, Xiao et al. (2014) stated that 81.5% of total women involved in their study 
were nulliparous. Hence, the prevalence of PE for nulliparous women was 1.92% and 
among all nulliparous PE women from the population, 74.1% developed mild PE and 
25.9% of women developed severe PE. Less development of severe PE in this population 
was due to high consumption of fruits and better daily lifestyle diet practiced among these 
women. 
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3.5.1.4 Multiple Gestations 
 
The incidence of PE in women with multiple gestations has been shown to be two to five 
times that of singleton pregnancy (Lazarov et al., 2016). They also reported that 15-20% 
of women with twins will develop PE in their pregnancy. In a retrospective cohort study to 
evaluate the risk of preterm delivery among PE women conducted by Henry et al. (2013), 
they showed that twin pregnancies were significantly more likely to develop severe PE and 
delivered preterm babies than singletons (RR: 5.7, 95% CI: 4.47, 7.26). Clinicians claimed 
that it was difficult in balancing the needs of a mother and her babies as preterm severe PE 
carried high morbidity. Besides, Paré et al. (2014a) also found that women with multiple 
gestations were three times higher odds of developing severe PE than those with a singleton 
pregnancy (Adjusted OR: 3.17, 95% CI: 1.78, 5.66). Thus, they suggested that multiple 
gestations need to be prevented when assisted reproductive technologies were used. 
 
3.5.1.5 Marital Status 
 
Some previous studies have evaluated the relationship between paternity change and risk 
of developing an adverse pregnancy outcome like PE. Bandoli et al. (2012) concluded that 
the odds of having PE in pregnancy were 2.75 times higher for women with partner 
changing compared to those who had not (Adjusted OR: 2.75, 95% CI: 1.33, 5.68). This 
finding was similar to a study done on pregnant women in Maryam Hospital located in 
Tehran, Iran as they found out that those with marriage more than once were 2.65 times 
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more likely to be associated with the development of a more serious PE condition 
(Allahyari et al., 2010).  
 
Tessema et al. (2015) proved that unmarried women were 3 times more likely to develop 
PE than those who were married (Adjusted OR: 3.03, 95% CI: 1.12, 8.20). This was due 
to the possibility of low preconception period seminal fluid exposure among unmarried 
women which could increase the risk of PE during pregnancy.  
 
3.5.2 Clinical Characteristics 
3.5.2.1 Previous PE History 
 
Women with PE history in their previous pregnancy had a significantly higher chance of 
developing another PE in next pregnancy with OR of 9.4, 5.46, and 3.63 respectively 
(Kashanian et al., 2011; Direkvand-Moghadam et al., 2012; Paré et al., 2014b). Recently, 
Sharami et al. (2017) asserted that the odds of developing PE were 3.2 times higher among 
women with previous PE history. They found that those with history of PE were 3.9 and 
4.2 times higher chance of getting both mild and severe PE respectively in the subsequent 
pregnancy (Adjusted OR: 3.93, 95% CI: 1.69, 9.14 vs Adjusted OR: 4.2, 95% CI: 1.58, 
11.3). This reflected that there was an association between PE and future risk of 
hypertension and heart diseases (Garovic and August, 2013). 
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Wong et al. (2013) observed that those with severe PE in previous pregnancy was 53.3% 
greater chance of getting PE in next pregnancy compared to those with mild PE in the 
previous pregnancy (16.7%). They concluded that previous PE history was proven to be a 
strong independent factor for gestational hypertensive disorders among high-risk pregnant 
women (Adjusted OR: 2.89, 95% CI: 1.18, 7.08). 
 
3.5.2.2 Chronic Hypertension 
 
Chronic hypertension is a prior problem in developing countries and it can increase the 
incidence of PE (Macdonald-Wallis et al., 2011). Paré et al. (2014b) reported that women 
with chronic hypertension were 3.2 times higher odds of developing severe PE compared 
to those without prior hypertension (Adjusted OR: 3.20, 95% CI: 2.06, 4.98). In addition, 
women with underlying chronic hypertension were 8.32 and 12.06 times more likely to 
develop PE and eclampsia with 95% CI of 7.13-9.72 and 8.40-17.31 respectively (Abalos 
et al., 2014). Direkvand-Moghadam et al. (2012) also found a significant association 
between chronic hypertension with the severity of PE (Adjusted OR: 2.34, 95% CI: 1.03, 
4.40).  
 
3.5.2.3 Family History of Hypertension and DM 
 
Tessema et al. (2015) concluded higher chance of PE was found among women in Ethiopia 
with family history of hypertension for about seven-fold (Adjusted OR: 7.17, 95% CI: 3.4, 
15.2), while odds of developing PE were 2.4 times higher among those with a family 
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history of DM (Adjusted OR: 2.40, 95% CI: 1.09, 5.6). Paré et al. (2014b) claimed that 
those with family history of PE was 74% higher odds of having severe PE in pregnancy 
than mild PE (Crude OR: 1.74, 95% CI: 1.10, 2.74).  
 
This result was supported by a study done by Bezerra et al. (2010) where they proved that 
women whose mothers had a history of hypertension (Adjusted OR: 1.46, 95% CI: 1.13, 
1.88), PE (Adjusted OR: 2.08, 95% CI: 1.22, 3.55), or eclampsia (Adjusted OR: 3.23, 95% 
CI: 1.06, 9.81) were at higher odds of getting severe PE. The chance of severe PE was also 
high when the woman had a sister with a history of hypertension (Adjusted OR: 2.60, 95% 
CI: 1.60, 4.21), PE (Adjusted OR: 2.33, 95% CI: 1.58, 3.45), or eclampsia (Adjusted OR: 
2.57, 95% CI: 1.28, 5.16). Notably, there was a significant association of getting severe PE 
among women with both mother and sister having a history of hypertension (Adjusted OR: 
3.65, 95% CI: 1.65, 8.09). 
 
3.5.2.4 History of Abortion 
 
Recently, Sepidarkish et al. (2017) stated that higher number of previous spontaneous 
abortion was associated with higher chance of developing PE among pregnant women 
(Adjusted OR: 1.28, 95% CI: 1.03, 1.59). In a cross-sectional study conducted in Alzahra 
Hospital, Rasht, Sharami et al. (2017) demonstrated that history of abortion was 2.72 times 
higher odds of developing mild PE (Adjusted OR: 2.72, 95% CI: 1.33, 1.56), and there was 
a significant mean difference among healthy pregnant and mild PE (P<0.019), as well as 
mild and severe PE (P<0.008). 
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3.5.2.5 History of Established DM and Gestational DM (GDM) 
 
Several studies demonstrated that there were significant associations between pre-existing 
DM and GDM among PE women. In a recent study conducted by Yang et al. (2017), those 
with GDM during pregnancy was about 16 fold more likely to develop PE (Adjusted OR: 
15.54, 95% CI: 5.82, 41.49). Besides, pre-existing DM was 3.88 times higher odds of 
getting PE when controlling for other confounders (Adjusted OR: 3.88, 95% CI: 2.08, 7.26) 
(Paré et al., 2014b). These were supported by a previous study done by Anderson et al. 
(2012) where GDM as well as type 1 and type 2 diabetes were significantly higher among 
PE women referred to Auckland City Hospital in New Zealand. 
 
3.5.2.6 Laboratory Parameters  
 
The combination of clinical data as well as the laboratory routine tests such as uric acid, 
creatinine, albumin, platelet count, urea, hemoglobin, AST, and ALT were very helpful in 
determining the severity of PE during pregnancy. Somani et al. (2015) concluded that 
serum uric acid level were usually elevated during pregnancy with PE and significantly 
higher among PE women (p<0.005). This was supported by other previous studies 
(Hawkins et al., 2012; Wu et al., 2012; Enaruna et al., 2014). Previously, Egwuatu (1986) 
claimed that overproduction of uric acid was due to excessive cellular activity associated 
with placental ischemia. They found that plasma urea and uric acid concentration were 
higher in patients with severe PE than those of mild/moderate PE, but no significant mean 
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difference between plasma creatinine and the severity of PE. Consequently, an increase in 
uric acid and urea among PE women had led to the complications of the fetus. 
 
Manaj et al. (2011) reported that PE occurred if platelet count was less than 100,000/µL. 
Hyperuricemia was found associated with PE and usually was tested early to predict later 
onset of PE. A serum uric acid level greater than 5 mg/dL was considered abnormal and 
was predicted as a marker of tubular dysfunction in PE. Usually serum creatinine was less 
than 0.8 mg/dL during pregnancy, thus higher levels suggest intravascular volume 
contraction or renal involvement in PE. Moreover, elevated levels of serum transaminases 
would lead to hepatic involvement in PE such as HELLP syndrome; a liver-related 
disorder. Features of PE occur in the majority of patients presenting with HELLP 
syndrome. Ten to 20% of patients with severe PE will develop HELLP (Hammoud and 
Ibdah, 2014).  
 
Murakami et al. (2000) suggested that the presence of hemoconcentration was due to 
hemoglobin level of more than 13 g/dL, while low level may be due to microangiopathic 
haemolysis or iron deficiency. Anemia was defined as haemoglobin level of less than 11 
g/dL (McLean et al., 2009). Ali et al. (2011) estimated the prevalence of PE and eclampsia 
for about 8.2% and 3.3% among women with severe anaemia respectively. PE was just 
significantly increased in severe anaemia group (Adjusted OR: 3.6, 95% CI: 1.40, 9.10) 
compared to the mild group, while there was no increase in risk for eclampsia among 
women with anaemia. After adjusted for all potential confounders, Taner et al. (2015) 
demonstrated that women with anaemia were 55% higher chance of developing PE 
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(Adjusted OR: 1.55, 95% CI: 1.03, 2.1) compared to those who did not. However, 
Kashanian et al. (2011) claimed that anaemia was protective for PE since there was no 
significant association between them. 
 
In a recent study done by Maged et al. (2017) among pregnant women in Cairo, Egypt, 
they found out that the platelet count was significantly lower in those of severe PE 
compared to mild, while there was no significant difference between creatinine, uric acid, 
urea, and AST between both mild and severe PE groups.  However, the ALT level was 
noted to be significantly higher among women with severe PE than mild. 
 
3.6 Ordinal Logistic Regression 
 
The statistical analysis applied in this study was the ordinal logistic regression. It is an 
extension of the binary logistic regression. The interest of logistic regression is to estimate 
the relationship between the binary outcome (dependent) variable and more than one 
explanatory (independent) variables which consist of the combination of numerical and 
categorical variables and also known as covariates. The main goal of the analysis of logistic 
regression is to find the best fit and most parsimonious, as well as biologically plausible 
model to explain the relationship between an outcome variable and the independent 
variables (Hosmer et al., 2013). 
 
A method of ordinal logistic regression is designed to take full advantage for analysing 
ranked outcomes and several associated factors. The primary characteristic of ordinal data 
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is that the numbers assigned to successive categories of the variable being measured 
represent differences in magnitude, or a “greater than” or “less than” quality (Stevens, 
1951). 
 
In this study, the severity of PE was assessed with scale categories of mild, moderate, and 
severe which showed an ordered ratings of the outcome variable. Knapp (1999) explained 
that the severity of illness categories represent increasing the severity, in the sense that 
“moderate” is more critical than “mild,” and “severe” is more critical than “moderate.” The 
rating given to the “severe” case does not imply that “severe” is three times as critical than 
“mild,” only that the severity of illness in the “severe” category is greater than the severity 
of illness for those in the “mild” category and greater still than those in the “moderate” 
category. 
 
Data that were used to be collected using an ordinal scale were rarely analysed as such 
since the methods of analysing ordinal data have not been widely applied (Scott et al., 
1997). Hence, they reported that ordinal data often be treated as nominal, with proportions 
calculated for each level of outcome. Chi-square tests of association are used to test the 
differences in proportions. However, chi-square tests have less optimal power, since they 
ignore the ordinality of the data which may yield to incorrect inferences. Some limitations 
of chi-square tests are, they are not amenable to statistical adjustments; the results are 
sample-size dependent, and no measure of association is produced. 
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The ordinal scale is usually collapsed into a dichotomous one and treated as a binary 
logistic model. The ordinal outcome will be forced into two levels, thus discarded some 
important information. Hence, it may lead to erroneous statistical inferences. 
 
Otherwise, the ordinal scale is quantified and treated as continuous and linear. Applying 
linear regression models to ordinal outcomes is troublesome as one of the assumption is 
that the variance of the outcome must be homogenous. However, the variance of ordinal 
data with an underlying multinomial distribution is not homogenous. Ordinary least square 
(OLS) regression is applied to this data, but the corresponding estimates of variance are 
biased and inconsistent (Lipsitz and Buoncristiani, 1994). 
 
Thus, fitting an ordinal logistic regression is preferable so that no information is lost. This 
analysis is powerful and the estimates produce a broad parameter interpretation that 
summarizes the effect between groups of all level of the outcome. 
 
There are various models in ordinal logistic regression. Hosmer et al. (2013) discussed that 
the most commonly used models are the adjacent-category, the continuation ratio, and the 
proportional odds models. In this study, only the proportional odds model was applied in 
assumption checking. Some other models that are less frequently used are the 
unconstrained partial-proportional odds, the constrained partial-proportional odds, and the 
stereotype logistic models. 
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In the ordinal model, outcomes needed to be decided to compare and determine what the 
most reasonable model is for the logit. If each response to the next larger response is 
compared, then the model that should be applied is the adjacent-category logistic model. It 
is a constrained version of the baseline logits. However, the continuation-ratio logistic 
model is about comparing each response to all lower responses that is Y = k versus Y < k 
for k = 1,2,…, K.  
 
The third most frequently used model for ordinal logistic regression is the proportional 
odds model (McCullagh, 1980; Hosmer et al., 2013). It is meant for comparing the 
probability of an equal or smaller response, 𝑌 ≤ 𝑘, to the probability of a larger response, 
𝑌 > 𝑘, for k = 0,1,…, K-1. It describes a less than or equal versus more comparison. It is 
also called the constrained cumulative logit model. The constrained placed on the model is 
that the log odds does not depend on the outcome category as the inferences from fitted 
proportional odds models are more on the direction of response rather than on specific 
outcome categories. Proportional odds model is derived via categorization of an underlying 
continuous response variable. Thus, some concepts from linear regression modeling is 
allowed to be used. One advantage of the proportional odds model that almost similar to 
the binary logistic model is that the direction of the model can be reversed by changing the 
signs of the coefficients to get the estimated odds ratio. Hence, the model chosen for ordinal 
logistic regression should consider an assessment of the model adequacy and which odds 
ratios are most informative for the problem. 
